Detalhe da pesquisa
1.
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma.
Anticancer Drugs
; 35(1): 63-69, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067996
2.
Initial treatment of patients with thyroid cancer: Outcomes and factors associated with care at academic versus nonacademic cancer centers.
Cancer
; 127(11): 1770-1778, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33449369
3.
Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities.
Clin Lymphoma Myeloma Leuk
; 19(10): 619-623, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31377212